Congo to use Ebola vaccine to counter flare-up

Four people have tested positive for Ebola


Democratic Republic of Congo (DRC) officials say they will start using Ebola vaccine to counter a flare-up in the heavily populated eastern part of the Central African country, according to an article on the Reuters website.

Four people have tested positive for Ebola in and around Mangina, a town of about 60,000 people in North Kivu province, about 60 miles) from the Ugandan border.  

Another 20 people died from unidentified hemorrhagic fevers in July. The World Health Organization (WHO) declared the ninth outbreak of Ebola in the Democratic Republic of the Congo (DRC) over on July 24, according to an article on WHO website. 

Unlike previous DRC Ebola outbreaks, this one involved four locations, including an urban center with river connections to the capital and to neighboring countries, as well as remote rainforest villages.

Read the article.

 

 



August 7, 2018


Topic Area: Infection Control


Recent Posts

Strategies to Eradicate Biofilm Containing C. Auris

Understanding the speed and risks of contamination after room disinfection should inform managers’ environmental cleaning recommendations.


Man Attacks Nurses, Police Officer at Jefferson Hospital

The man allegedly attacked the staff members before being restrained and sedated.


Freeman Health System Breaks Ground on New Full-Service Hospital

The construction project will be completed in three phases, over a 24- to 34-month time period.


All Eyes on Gen Z as They Enter the Workforce

As the labor gap widens in the facilities industry, not many managers trust Gen Z to fill that hole.


Cleveland Clinic Starts Fundraising Effort for New Hospital in West Palm Beach

Plans for the new hospital include approximately 150 inpatient beds, an emergency department, a medical office building and an ambulatory surgery center.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.